Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Corash

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Transfusion|September 1, 2005
Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentratesIris Bruchmüller, Karin Janetzko, Peter Bugert, et al.
Transfusion|January 31, 2026
Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchangeFlorian Tupin, Clarisse Mouriaux, Beatrice Hechler, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
Transfusion|January 16, 2026
Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complexFlorian Tupin, Clarisse Mouriaux, Michelle Gatmaitan, et al.
Transfusion|February 21, 2023
Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storageJohn P Pitman, Jean-Marc Payrat, Min-Sun Park, et al.
Transfusion|August 14, 2019
Acute Zika virus infection in an asymptomatic blood donor at the onset of the Puerto Rico epidemicPaula Saa, Charles Chiu, Kacie Grimm, et al.
Annals of Hematology|April 20, 2011
Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patientsPeter Schlenke, Wibke Hagenah, Johannes Irsch, et al.
The Journal of Infectious Diseases|November 17, 2006
Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplificationJean-Pierre Allain, Jocelyn Hsu, Manisha Pranmeth, et al.
Transfusion|February 3, 2017
Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6<sup>o</sup> CAnna Erickson, Katie Waldhaus, Tovo David, et al.
Transfusion|September 24, 2004
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaLily Lin, Roberta Dikeman, Barbara Molini, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Transfusion|September 1, 2005
Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentratesIris Bruchmüller, Karin Janetzko, Peter Bugert, et al.
Transfusion|January 31, 2026
Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchangeFlorian Tupin, Clarisse Mouriaux, Beatrice Hechler, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
Transfusion|January 16, 2026
Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complexFlorian Tupin, Clarisse Mouriaux, Michelle Gatmaitan, et al.
Transfusion|February 21, 2023
Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storageJohn P Pitman, Jean-Marc Payrat, Min-Sun Park, et al.
Transfusion|August 14, 2019
Acute Zika virus infection in an asymptomatic blood donor at the onset of the Puerto Rico epidemicPaula Saa, Charles Chiu, Kacie Grimm, et al.
Annals of Hematology|April 20, 2011
Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patientsPeter Schlenke, Wibke Hagenah, Johannes Irsch, et al.
The Journal of Infectious Diseases|November 17, 2006
Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplificationJean-Pierre Allain, Jocelyn Hsu, Manisha Pranmeth, et al.
Transfusion|February 3, 2017
Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6<sup>o</sup> CAnna Erickson, Katie Waldhaus, Tovo David, et al.
Transfusion|September 24, 2004
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaLily Lin, Roberta Dikeman, Barbara Molini, et al.
Pageof 7